Achieve Life Sciences, Inc.
ACHV
$2.26
$0.0753.44%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 16.25M | 13.63M | 11.76M | 11.58M | 11.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.07M | 31.27M | 25.37M | 24.65M | 27.25M |
| Operating Income | -39.07M | -31.27M | -25.37M | -24.65M | -27.25M |
| Income Before Tax | -39.83M | -32.94M | -27.54M | -27.32M | -29.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -39.83 | -32.94 | -27.54 | -27.32 | -29.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.83M | -32.94M | -27.54M | -27.32M | -29.82M |
| EBIT | -39.07M | -31.27M | -25.37M | -24.65M | -27.25M |
| EBITDA | -38.84M | -31.04M | -25.14M | -24.43M | -27.02M |
| EPS Basic | -1.23 | -1.13 | -1.10 | -1.29 | -1.53 |
| Normalized Basic EPS | -0.75 | -0.68 | -0.67 | -0.79 | -0.94 |
| EPS Diluted | -1.23 | -1.13 | -1.10 | -1.29 | -1.53 |
| Normalized Diluted EPS | -0.75 | -0.68 | -0.67 | -0.79 | -0.94 |
| Average Basic Shares Outstanding | 128.23M | 114.89M | 101.66M | 86.39M | 79.26M |
| Average Diluted Shares Outstanding | 128.23M | 114.89M | 101.66M | 86.39M | 79.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
